Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › CVS Health › Director received an award of 1,775 CVS shares Insider trades
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Nov 20, 2025
Reporting period Not applicable
Filed with the SEC Nov 21, 2025 Director Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0000064803-25-000059
Filed / recorded
Nov 21, 2025, 10:38 PM UTC
Added to OQRO Oct 2, 2026, 3:52 AM UTC
Data quality Verified: identifiers matched exactly
Reporting person C David Ii Brown
Table Non-derivative (Table I)
Transaction date Nov 20, 2025
Acquired / disposed Acquired (A)
Shares owned after 127,772
Footnotes from the filing Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
Around the same time Congress
Traded Nov 21, 2025 · disclosed 28 days later Sits on House Ways and Means, Health
4 different filers disclosed CVS within 90 days.
Insider filing
Traded Nov 30, 2025 · filed 2 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Nov 30, 2025 · filed 2 days later
Routine share withholding; mechanical by default.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Sep 9, 2024 Insider · Their first buy on record Officer purchased ~$2K of CVS shares in the open market Oct 2, 2024 Insider · Bought outside the usual window Officer purchased ~$622 of CVS shares in the open market Oct 23, 2024 Insider Officer purchased ~$2K of CVS shares in the open market Jan 23, 2025 Insider · Bought outside the usual window Officer purchased ~$1.3K of CVS shares in the open market Sep 23, 2025 Congress Disclosed sale of CVS — reported range $1,001 - $15,000 Oct 29, 2025 Company filing · Form 8-K · Results Reported its results Oct 30, 2025 Congress · 1 person Members of Congress: 1 purchase, 1 sale Oct 31, 2025 Congress Disclosed sale of CVS — reported range $1,001 - $15,000 Nov 19, 2025 Government · Federal Register notice United States v. Hewlett Packard Enterprise Co. and Juniper Networks, Inc.; Response of the United States to Public Comments on the Proposed Final Judgments What came next Nov 21, 2025 Congress Disclosed sale of CVS — reported range $1,001 - $15,000 Jan 29, 2026 Congress Disclosed purchase of CVS — reported range $1,001 - $15,000 Feb 10, 2026 Company filing · Form 8-K · Results Reported its results Mar 18, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On March 18, 2026, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected John E. Gallina to serve on the Board, effective March 19, 2026.”